Trial Profile
Short- and long-term colectomy rate in patients treated with infliximab for severe corticosteroid-refractory ulcerative colitis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Dec 2015
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 16 Dec 2015 New trial record